Impact of human metapneumovirus infection on in and outpatients for the years 2006-2008 in Southern Brazil Maria C Debur; Luine RR Vidal; Elenice Stroparo; Meri B Nogueira; Sérgio M Almeida; Gislene A Takahashi; Indianara Rotta; Luciane A Pereira; Clyete S Silveira; Adriana Delfraro; Sueli M Nakatani; Irene Skraba; Sonia M Raboni PAGE: 1010-1018 | DOI: 10.1590/S0074-02762010000800010

Molecular epidemiology of HIV-1 clades in Southern Brazil Sonia Mara Raboni; Sérgio Monteiro de Almeida; Indianara Rotta; Cléa Elisa Lopes Ribeiro; Debra Rosario; Luine Rosele Vidal; Meri Bordignon Nogueira; Maristela Riedel; Maria da Graça Winhescki; Kátia Antunes Ferreira; Ronald Ellis PAGE: 1044-1049 | DOI: 10.1590/S0074-02762010000800015

Comparison of the epidemiology, profile of mutations, and clinical response to antiretrovirals among subtypes B and F of the human immunodeficiency virus type 1 Heloisa Ramos Lacerda; Luzidalva Barbosa de Medeiros; Ana Maria Salustiano Cavalcanti; Ricardo Arraes de Alencar Ximenes; Maria de Fátima Pessoa Militão de Albuquerque PAGE: 693-699 | DOI: 10.1590/S0074-02762007005000103

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil Ana Maria Salustiano Cavalcanti; Heloisa Ramos LacerdaII; Ana Maria de Brito; Sirleide Pereira; Daniela Medeiros; Suelene Oliveira PAGE: 785-792 | DOI: 10.1590/S0074-02762007005000109

Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil Luzidalva Barbosa de Medeiros, Heloísa Ramos Lacerda, Ana Maria Salustiano Cavalcanti, Maria de Fátima Pessoa Militão de Albuquerque PAGE: 845-849 | DOI: S0074-02762006000800004

A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality Walter A Eyer-Silva, Mariza G Morgado PAGE: 869-873

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy JC Couto-Fernandez, C Silva-de-Jesus, VG Veloso, M Rachid, RSG Gracie, SL Chequer-Fernandez, SM Oliveira, D Arakaki-Sanchez, PJN Chequer, MG Morgado PAGE: 73-78